Research Article
The Long-Term Outcome Comparison of Different Time-Delayed Kallikrein Treatments in a Mouse Cerebral Ischemic Model
Figure 5
Administration of exogenous tissue kallikrein starting at 8 h, 24 h, and 36 h after ischemic stroke can increase vWF+ cells (c–e) compared with the MCAO group in the peri-infarction region. (f) Quantitative data of vWF+ cells in the peri-infarction region (Mean ± SD). compared with the MCAO group. compared with the sham group. compared with the KLK 24 h group and KLK 36 h group. The scale bar represents 50 μm.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |